PERSPECTIVES
JOINT/COUNTERJOINT THIS MONTH, THE LEAF DEBATES...PHARMACEUTICAL POT
Counterjoint? Are you with Joint or on the issue of Where do you stand and style pharmaceutical-scale methods? d an g win Cannabis gro t oin erj int tCo oin #J
Each month, we task two Leaf Nation contributors to debate both sides of a controversial subject. As with all debates, these are assigned positions that are being defended for the sake of an argument and education, and do not necessarily represent the opinions of the writer, our staff, or our organization.
14
‘‘
neleafmag.COM
While the average stoner is drooling over the Weedmaps menu in legal states, big pharma has been plotting their profit-driven takeover of pot for the last 20 years.
Should we turn our natural plant over to the same big pharma JOINT BY WES ABNEY companies that poisoned our country for profit with opiates and massive overprescription of pills? I say no!
The future of Cannabis medicines will certainly involve science – so don’t take me for a “whole plant and nothing but the plant” type of activist. After all, I love getting scientifically processed and purged concentrates that are tested for harmful pesticides and chemicals, which produces a much tastier product than the open-blasted BHO of my Cannabis youth. But we must not let our quest for safer products lead to handing control of our plant over to either government regulators or big pharma. Cannabis has been consumed by humans for thousands of years, and many states are still fighting to have access to Cannabis medicine, let alone getting baked recreationally. While the average stoner is drooling over the Weedmaps menu in legal states, big pharma has been plotting their profit-driven takeover of pot for the last 20 years. Need proof? Google Sativex – GW Pharmaceuticals’ attempt to patent and control Cannabis medicine in the UK and beyond, with a terrible synthetic version of a tincture that can be made in any home kitchen. There’s also the Phylos BioScience betrayal of thousands of growers – who submitted their genetics to learn about their plants’ lineage – but later learned Phylos was harvesting information to submit patents and had ties to big pharma money. Their goal? To create genetically modified plants that can be grown with minimal human contact. Personally, I want to smoke GMO (Grandpa’s Mouth Odor) flower, not genetically modified garbage from a mega-grow. We’ve proven in the last decade that Cannabis provides incredible benefits naturally, whether by smoking the flower, vaporizing concentrates, eating edibles or extracts like FECO, or through topicals and transdermals. There are thousands of high-end products that are produced naturally, with love, by a human being paid to get their hands dirty as they grow our favorite plant. Do we need big pharma to change this? Absolutely not. We should free the plant for all people to grow and share, not regulate it further and take it out of the soil and the hands of farmers. You can make nearly every product necessary for a medicinal treatment in your kitchen, and anything you can’t is readily available from a focused, local craft producer. That is freedom – choosing our own medicine, who makes it, and with an intention to heal – not just profit.
FEB. 2021
COUNTERJOINT BY TOM BOWERS There’s a simple beauty in being able to plant a seed and grow your own medicine.
As homegrown, plant-based therapy, Cannabis provides safe, clean relief for millions of people. But not everyone can grow their own Cannabis plants. In fact, most people can’t – and those people rely on increasingly larger companies to produce their medicine. Cannabis continues to transform from homegrown medicine into large-scale industry, and as more and more consumers come to rely on its benefits for their lives, it’s a foregone conclusion that the modern pharmaceutical and medical industry will play a role in this growth. It’s already happening. While this development will bring its share of complicated downsides – these are the same people accountable for the opioid crisis, after all – there are upsides to the situation. When it comes to When it comes to medicine, a few indispensable traits come to medicine, a few mind: It needs to be clean. It needs to be consistent. It needs to be indispensable traits precisely dosed. It needs to be widely available. come to mind: It needs to The modern pharmaceutical industry already has the infrabe clean. It needs to be consistent. It needs to be structure, distribution channels, standards and processes to meet precisely dosed. It needs these criteria. Their labs are among the most clean, controlled to be widely available. environments on the planet – and they are accustomed to producing and distributing billions of precisely dialed doses of their medicines globally, with an efficiency so ingrained that it almost seems effortless. Imagine what that level of organization could do for bringing Cannabis medicine to people all over the globe... Sure, there are glaring downsides. In a bloodthirsty quest for shareholder value, the pharmaceutical industry will attempt to patent genetics and processes, seek to outlaw home cultivation, and will no doubt try to force their own, proprietary synthetic cannabinoid blends on the public. It’s like that person you work with who’s amazing at their job, but is also a complete asshole. We will have to learn to work with the modern medical industry before we get to where we’re going – that’s unavoidable. We need to be creative and unwavering in our fight for the plant and the rights of the people who rely on it, and at the same time, try to reap the benefits of infrastructure provided by a monolithic global capitalistic behemoth – without being destroyed in the process. Easy-peasy.
‘‘
A DEBATE by WES ABNEY @BEARDEDLORAX & TOM BOWERS @PROPAGATECONSULTANTS/LEAF NATION
